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Abstract:
Introduction: Data regarding the association between diabetes mellitus (DM) and tuberculosis (TB) in Africa are scarce. DM 
screening among TB patients in Mozambique was carried out.
Methods: The study was implemented from January to August 2016 in three Urban Health Centers in Beira, Mozambique and 
recruited adult (>18 years) patients newly diagnosed with pulmonary TB.
Results: Three hundred and one  patients were enrolled (67.4%, males mean age 31.7(SD 11 years). Diabetes was diagnosed in 
only 3 patients (1%) and impaired glucose tolerance (IGT) in an additional 6 subjects (2%).
Conclusion: A lower than expected prevalence of  DM was observed, which could be explained by the lack of  traditional risk 
factors for DM (overweight, age over 45 years, hypertension and smoking) in Mozambique.
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Introduction
Tuberculosis (TB) is one of  the leading causes of  death 
worldwide. Mozambique represents one of  the most af-
fected countries in the world, with an estimated preva-
lence of  over 500 per 100,000 population1. Although 
great efforts have already been made, the way to defeat 
TB remains long.  The WHO End TB Strategy aims to a 
90% reduction in TB deaths and an 80% reduction in the 
TB incidence rate by 20301.
Many factors contribute to the lack of  efficacy in contain-
ing TB, as social determinants of  health (SDH) and con-
comitance of  other co-morbidities, such as co-infections 
(in particular with HIV) and non-communicable diseases, 
such as diabetes mellitus (DM)2.
SDH, which can be defined as conditions in which people 
are born, grow, live, work and get old, are strongly influ-
enced by the distribution of  wealth, power, resources and 
they have an immediate impact on health2. In fact, it is 
well known the association between low socio-economic 
levels and TB3. Furthermore, TB is the most common 
opportunistic infection among HIV-positive patients and, 
especially in sub-Saharan Africa, the burden of  HIV/TB 
co-infection is the highest worldwide, with almost 80% 
of  all cases of  incident TB in persons with HIV infec-
tion4.
Growing evidence suggests that TB and DM represent 
a mutual risk factor of  occurrence of  each other5, caus-
ing also a reciprocal worsening, due to both pathogenic 
mechanisms6,  and metabolic factors7. In fact, if  on one 
hand patients with DM have a higher risk of  acquiring 
TB, on the other hand, patients with DM and TB have 
a high likelihood of  delayed diagnosis, healing, and in-
creased severity of  symptoms and mortality for both dis-
eases8.  Nowadays, sub-Saharan Africa and low income 
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countries are increasingly affected by DM9-10 and, the in-
creasing frequency of  DM co-existing with TB and HIV, 
is an example of  interaction between communicable and 
non-communicable diseases, requiring a multidisciplinary 
and integrated approach8. In Mozambique, data on the 
prevalence of  DM in TB patients are limited. The few 
data available on DM in this country in the general popu-
lation shows a national prevalence of  2.9%11-12, and peo-
ple are often unaware of  their condition11-12. The present 
study aimed to assess the prevalence of  DM in patients 
newly diagnosed with pulmonary TB in Beira, the second 
largest city in Mozambique, to better define the relation-
ship between TB and DM.
Patients and methods
Study design and population
This study took place in three urban health centres of  
Beira city involved in the National Tuberculosis Con-
trol Programme (PNCT): Ponta-Gea, Munhava and Ma-
curungo, that are largest in Sofala’s Province. The study 
was implemented from January to August 2016 and we 
recruited a total of  301 patients who were newly diag-
nosed with pulmonary TB. Inclusion criteria were: age 
≥18 years, a confirmed TB diagnosis (positive sputum 
smear result or GeneXpert positive result or culture pos-
itive result) and starting of  anti-TB treatment. Exclusion 
criteria were: previous TB treatment or TB treatment 
started within the previous two months. Informed  con-
sent was  requested from all enrolled patients. Anti-TB 
treatment was prescribed according to guidelines of  the 




A face-to-face interview conducted by a trained nurse 
encompassed questions about demographic characteris-
tics (age, residence, education, occupation, marital status, 
monthly income), possible pregnancy, risk behaviours 
(sexual behaviour/partnerships, concurrent sex partners, 
condom use, smoke and alcohol abuse, etc.) and medi-
cal history, including TB and diabetes symptoms. A basic 
physical examination (vital signs, weight, height, waist cir-
cumference, blood pressure and general appearance) was 
performed. The body mass index (BMI) was calculated. 
Moreover, subjects with unknown HIV status received a 
pre-HIV test, other suggestion to undergo a rapid HIV 
test, if  not done before. For the diabetes diagnosis, two 
consecutive fasting blood glucose tests were performed 
to each participant. We did a screening and diagnosis for 
TB infection according to clinical, microbiological and 
radiological algorithm established by the WHO Guide-
lines for patients with or without HIV infection1 and in 
patients with TB infection, the clinical severity was  evalu-
ated based on extension, site and number of  localizations 
of  disease (pulmonary/extrapulmonary).  According to 
the WHO guidelines, patients were considered as non-di-
abetic if  both measurements were ≤110 mg/dl, and as di-
abetic if  both measurement were above 126 mg/dl. If  at 
least one value was between 110 and 126 mg/dl, the Oral 
Glucose Tolerance Test (OGTT) was performed: patients 
were considered diabetic when plasma glucose at 2 hours 
was ≥200 mg/dl14.
All TB-diabetic patients underwent fundus examination, 
urinary stick and assessment of  diabetic complications.
 
Statistical analysis
Data obtained from the answers to the questionnaire 
were imported on Excel 5.0 and analysed using the STA-
TA 13.0  software.
Mean and standard deviation for continuous variables 
and frequency for categorical variables were calculated as 
descriptive statistics. Due to the small number of  diabetic 
patients, a comparison between diabetic and non-diabetic 
subjects was not possible.
Ethical approval
The study was approved by the Comité Nacional de Bio-
etica para a Saúde/ National Bioethics Committee for 
Health by the protocol Ref: 168/CNBS/15.
Results
Socio-demographic characteristics
The social-demographic characteristics of  the study pop-
ulation and patients’ life style are reported in Table 1. The 
301 patients with a new diagnosis of  pulmonary TB in-
cluded  203 males (67.4%) and 98 females (32.6%), mean 
age 36.7 years. Nearly a half  141 patients (47.5%) had no 
educational degree; 157 (52.9%)  patients were employed 
and only 10 (3.8%) had a monthly income higher than 100 
Euros. Only 7 patients (2.4%) claimed to have more than 
one sexual partner and 32 (11.3%) stated to always use 
condoms. The majority of  subjects 274 (93.2%) declared 
non smoking while alcohol consumption was moderate, 
and only 2 patients (0.7%) were daily drinkers.
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Table 1: Socio-demographic and lifestyle characteristics 
 
Variable N. (%) 
Numberof cases examined 301 
Gender   
Female   98 (32.6%) 
Male   203 (67.4%) 
Age 
 
Mean age (years)                                                                                                  
  
 36.7  
  Range (years)                                                              18 – 83 
  
Educational degree   
None   141 (47.5%) 
Primary school   125 (42.1%) 
Secondary school 25 (8.4%) 
University degree  6 (2.0%) 
Occupation   
Unemployed   95  (32%) 
Housewife      18 (6%) 
Student           27 (9.1%) 
Worker           157 (52.9%) 
  
Monthly income (Euro)   
None   106   (40.8%) 
< 25      29  (11.2%) 
 25- 50  53  (20.4%) 
50 – 100  62 (23.8%) 
    > 100    10 (3.8%) 
  
BMI   
Severe thinness 59 (19.6%) 
Moderate thinness     32 (10.6%) 
Light Thinness 78  (26%) 
Healthty     128  (42.5%) 
Overweight 4  (1.3%) 
Sexual partner/s   
No    110   (37.4%) 
One  177   (60.2%) 
More than one  7  (2.4%) 
Condom Use   
Never   131  (46.1%) 
Sometimes  121  (42.6%) 
Always        32    (11.3%) 
Smoking   
No    274    (93.2%) 
1-5/day  15   (5.1%) 
20/day    5   (1.7%) 
Alcohol drinking   
No        260  (87.8%) 
Once a week   34  (11.5%) 
Every day   2  (0.7%) 
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Clinical and laboratory characteristics
The main laboratory and clinical characteristics are shown 
in Table 2. The most sensitive test for TB diagnosis was 
GeneXpert, which was positive in 56 of  58 (96.6%). A 
chest X-ray was performed for 155/301 subjects and 148 
of  155 (95.5%) showed TB-compatible lesions.
The HIV status was known for 282 patients: of  them, 
161 (57.1%) were positive. Sixty-six patients (26.7%) were 
on anti-retroviral treatment (ART). The BMI was below 
healthy range in 169 (55.6%) whereas 4 subjects (1.3%) 




Table 2 Clinical and laboratorial characteristics 
 
Variable N. (%) 
Sputum Examination   
Negative  50  (16.9%) 
Positive    246 (83.1%) 
Sputum colture   
Negative   3   (75%) 
Positive   1 (25%) 
GeneXpert   
Negative   2   (3.4%) 
Positive    56  (96.6%) 
Chest X-ray   
Negative   7 (4.5%) 
Positive     148 (95.5%) 
HIV   
Negative  121  (42.9%) 
Positive     161  (57.1%) 
ART   
Yes       66    (26.7%) 
No      181   (73.3%) 
Diabetes   
Yes   3 (1%) 
No 290 (97%) 
IGT     6 (2%) 
High Blood Pressure   
Yes 1   (0.3%) 
No   293 (99.7%) 










Diabetes was diagnosed in only 3 patients (1%) and IGT 
in additional 6 subjects (2%). Nobody was aware of  their 
diabetic status.
Reported clinical signs and symptoms are summarized in 
Table 3. The most frequent TB symptoms were: cough 
(90.9%), weight loss (88.2%), asthenia (58.8%) and fever 
(58.8%). The patients with DM and IGT reported weight 
loss, polyuria and asthenia. 
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Table 3 Main symptmoms reported from patients with pulmonary TB 
 
Symptoms N. (%) 
No symptoms   3     (1%) 
Cough  269 (90.9%) 
Fever  174  (58.8%) 
Astenia  215 (72.6%) 
Dyspnea  95 (32.1%) 
Hemoptysis   4 (1.4%) 
Night sweats  118  (39.9%) 
Weight loss    261  (88.2%) 
Polyuria         13   (4.4%) 
Polydipsia       7  (2.4%) 




In sub-Saharan Africa, there is an emerging strong cor-
relation between communicable and non-communicable 
diseases due to the long lasting presence of  epidemic in-
fections such as HIV and TB and the increasing incidence 
of  chronic diseases as DM and hypertension. In 2030, 
people living with diabetes in Africa are estimated to rise 
from 21.1 million in 2010 to up to 23.9 million15. In the 
same area, DM causes about 4.9 million deaths per year 
and approximately 76% of  these deaths occur in people 
aged less than 60 years9. Diabetes is considered among 
priorities in the National Strategic Plan for the prevention 
and control of  non communicable diseases also in Mo-
zambique13. However, the prevalence of  DM seems to be 
quite low, around 3% in the general population aged from 
25 to 64 years old, and it is higher among people living in 
rural areas11. Our study showed a low prevalence of  DM 
in newly TB-diagnosed patients (1%) compared to data 
regarding the general population, although a disorder in 
glycometabolic control was found in 3% of  subjects. 
This finding in our population could be explained by the 
lack of  some of  the risk factors recognised for the on-
set of  DM, including overweight, age over 45 years, hy-
pertension and smoking14. In fact, in our population the 
mean age was 36.7 with only few patients overweight and 
affected by hypertension. Indeed, two out of  three dia-
betic patients in our study were older than 45 years and 
were smokers, whereby one subject was HIV positive. 
Among the six patients with IGT the median age was 32, 
there was no smoking, three were HIV positive and one 
consumed alcohol. 
In low-income countries, the association between TB and 
DM is variable, ranging from 1.9% to 35%14. Other au-
thors reported a higher incidence of  DM in TB patients 
from African countries or low income settings10-16. On the 
contrary, other studies showed a low association of  DM 
and TB in low-income settings17, which was explained by 
the young age of  enrolled patients, similarly to the results 
of  the present study18-19.
Furthermore, this study underlines the importance of  
other factors associated with the onset of  TB, including 
SDH. The phenotype of  newly diagnosed patients with-
pulmonary TB in Beira was outlined: patients are mainly 
young, underweight, with a low educational background 
and low income, without smoke nor alcohol habits, ba-
sically without hypertension and diabetes mellitus but in 
most cases living with HIV infection. According to our 
data, SDH appear to influence the onset of  TB but also 
the frequency of  MDR and the adherence to therapy3. 
HIV is the most well known disease associated with TB; 
and our data confirms this correlation as almost 60% 
of  patients with a known HIV status were seropositive. 
On the other hand, additional risk factors for TB such 
as smoking and alcohol use, are almost inexistent in our 
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study. A limitation of  our study is that, our data could be 
biased because they were not verified and were based on 
personal interview. Another drawback of  the study is the 
small sample size and  lack of  a control group.
Conclusion
Our study shows a low prevalence of  DM in newly diag-
nosed patients with pulmonary TB in Mozambique. The 
lower than expected DM prevalence, however, does not 
clash with the hypothesis of  a mutual interaction exist-
ing between these two diseases. Future studies enrolling 
a greater number of  diabetic patients would be crucial in 
order to assess definitive epidemiological data to contrib-
ute to the TB End Strategy in one of  the most affected 
countries like Mozambique.
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